Literature DB >> 32144721

History, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes : Centenarian IgGs lost their neutralization capacity.

Nicolas Aubert1, Marie Brachet-Botineau2, Giulia Emi de Olivera Preto3, Isabelle Benz-de Bretagne4,5, Hervé Watier1,6, Guillaume Brachet7,8.   

Abstract

During World War I (WWI), infectious diseases including tetanus were among the most important causes of death. Even though its efficacy was somewhat controversial before the war, tetanus antiserum played a key role in reducing the mortality of this disease. A vial of tetanus antiserum dating back from WWI, left behind on the French battlefield by the US Army, was borrowed from a private collection and opened. The serum contained within was characterized by orthogonal biochemical techniques to determine if any neutralizing IgGs could remain after 100 years of storage. In vitro analysis by Size Exclusion Chromatography and Serum Protein Electrophoresis suggested the presence of residual IgG. In spite of our hopes, these IgGs were not able to protect mice against tetanus toxin challenge in a neutralizing assay. Even though our results indicate the presence of remaining IgGs inside the serum, they were functionally disabled. These results show that obscurity alone is insufficient to protect IgGs from degradation over very long periods of time at room temperature. HIGHLIGHTS: Tetanus antiserum found its place in the therapeutic arsenal during World War I A century-old vial of tetanus antiserum was opened for biochemical and in vivo characterization Biochemical assays revealed the presence of proteins having all the characteristics of IgGs The serum was unable to protect mice against toxinic challenge.

Entities:  

Keywords:  Antiserum; IgG; Stability; Tetanus; World War I

Mesh:

Substances:

Year:  2020        PMID: 32144721     DOI: 10.1007/s12026-020-09121-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  8 in total

1.  Prevention of tetanus during the First World War.

Authors:  Peter Cornelis Wever; Leo van Bergen
Journal:  Med Humanit       Date:  2012-04-29

Review 2.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

3.  NOTE ON THE INCIDENCE OF TETANUS AMONG WOUNDED SOLDIERS.

Authors:  D Bruce
Journal:  Br Med J       Date:  1917-01-27

4.  The Treatment of Tetanus by the Intracerebral Injection of Antitoxin: With Particulars of a Case Treated by this Method, Followed by Recovery.

Authors:  D Semple
Journal:  Br Med J       Date:  1899-01-07

5.  Tetanus Antitoxin; Its Preparation and Properties.

Authors:  R T Hewlett
Journal:  Br Med J       Date:  1895-03-02

6.  Stability of selected serum proteins after long-term storage in the Janus Serum Bank.

Authors:  Randi E Gislefoss; Tom K Grimsrud; Lars Mørkrid
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

7.  [The mechanism of diphtheria immunity and tetanus immunity in animals. 1890].

Authors:  E von Behring; S Kitasato
Journal:  Mol Immunol       Date:  1991-12       Impact factor: 4.407

8.  Contribution of physiologists to the identification of the humoral component of immunity in the 19th century.

Authors:  Yves-Marie Lahaie; Hervé Watier
Journal:  MAbs       Date:  2017-05-30       Impact factor: 5.857

  8 in total
  1 in total

1.  Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial.

Authors:  Nguyen Van Hao; Huynh Thi Loan; Lam Minh Yen; Evelyne Kestelyn; Duc Du Hong; Duong Bich Thuy; Nguyen Thanh Nguyen; Ha Thi Hai Duong; Tran Thi Diem Thuy; Phung Tran Huy Nhat; Phan Nguyen Quoc Khanh; Nguyen Thi Phuong Dung; Nguyen Hoan Phu; Nguyen Thanh Phong; Pham Thi Lieu; Pham Thi Tuyen; Bui Thi Bich Hanh; Ho Dang Trung Nghia; Pham Kieu Nguyet Oanh; Phan Vinh Tho; Tran Tan Thanh; Hugo C Turner; H Rogier van Doorn; Le Van Tan; Duncan Wyncoll; Nicholas Pj Day; Ronald B Geskus; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  Lancet Glob Health       Date:  2022-06       Impact factor: 38.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.